{"DataElement":{"publicId":"2969453","version":"1","preferredName":"Specimen Inflammation Change Category","preferredDefinition":"Classification of tissue based on the amount of inflammatory changes present in a specimen.","longName":"CELL_INFLM_CHG_CAT","context":"SPOREs","contextVersion":"2.31","DataElementConcept":{"publicId":"2009355","version":"3","preferredName":"Specimen Inflammation Change","preferredDefinition":"related to evidence of alteration in a sample of tissue or blood collected for medical research which indicates a response of redness or swelling resulting from injury, disease or treatment.","longName":"SPEC_INFLM_CHG","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2241613","version":"1","preferredName":"Specimen","preferredDefinition":"Specimen; a bit of tissue or blood or urine that is taken or used for research purposes.","longName":"C19157","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Specimen","conceptCode":"C19157","definition":"A part of a thing, or of several things, taken to demonstrate or to determine the character of the whole, e.g. a substance, or portion of material obtained for use in testing, examination, or study; particularly, a preparation of tissue or bodily fluid taken for examination or diagnosis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F9FD4EEB-2242-0B27-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-07-08","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-07-08","modifiedBy":"ONEDATA","dateModified":"2005-07-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2452698","version":"1","preferredName":"Inflammation Change","preferredDefinition":"A response of redness, swelling, pain, and a feeling of heat in certain areas that is meant to protect tissues affected by injury or disease.:alteration or modification.","longName":"C3137:C25446","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Inflammation","conceptCode":"C3137","definition":"A finding of a localized protective response resulting from injury or destruction of tissues. Inflammation serves to destroy, dilute, or wall off both the injurious agent and the injured tissue. In the acute phase, inflammation is characterized by the signs of pain, heat, redness, swelling, and loss of function. Histologically, inflammation involves a complex series of events, including dilatation of arterioles, capillaries, and venules, with increased permeability and blood flow; exudation of fluids, including plasma proteins; and leukocyte migration into the site of inflammation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Change","conceptCode":"C25446","definition":"The act of alteration or modification; changed or altered in form or character.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0D51E8D8-67EA-387C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-23","endDate":null,"createdBy":"PWEST","dateCreated":"2006-02-23","modifiedBy":"ONEDATA","dateModified":"2006-02-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008547","version":"1","preferredName":"Specimen Characteristics","preferredDefinition":"attributes of a patient's laboratory sample, including the source, condition, and fixative.","longName":"SPEC_CHAR","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22908C4-638F-4A74-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0D052842-7E4C-4FD3-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-23","endDate":null,"createdBy":"PWEST","dateCreated":"2006-02-23","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"updated for ISO 11179 compliance","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2969451","version":"1","preferredName":"Cell Inflammatory Change Category","preferredDefinition":"The smallest units of living structure capable of independent existence, composed of a membrane-enclosed mass of protoplasm and containing a nucleus or nucleoid._Relating to inflammation._The act of alteration or modification; changed or altered in form or character._Category; used informally to mean a class of things.","longName":"CELL_INFLM_CHG_CAT","context":"SPOREs","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"8","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Mild","valueDescription":"Mild","ValueMeaning":{"publicId":"2563414","version":"1","preferredName":"Mild","longName":"2563414","preferredDefinition":"Not severe or strong; far from extreme; not serious enough to endanger life.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mild","conceptCode":"C70666","definition":"Gentle or temperate in nature or degree.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-C4C3-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-10-11","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-11","modifiedBy":"COOPERM","dateModified":"2008-10-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7AC59585-5F61-0358-E040-BB89AD436BCF","beginDate":"2009-12-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-12-15","modifiedBy":"ONEDATA","dateModified":"2009-12-15","deletedIndicator":"No"},{"value":"Absent","valueDescription":"Absent","ValueMeaning":{"publicId":"2566329","version":"1","preferredName":"Absent","longName":"2566329","preferredDefinition":"Not existing in a specified place at a specified time.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Absent","conceptCode":"C48190","definition":"Not existing in a specified place at a specified time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D026-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-08-05","endDate":null,"createdBy":"CHANGM","dateCreated":"2003-08-05","modifiedBy":"SOKKERL","dateModified":"2019-07-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7AC59585-5F6C-0358-E040-BB89AD436BCF","beginDate":"2009-12-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-12-15","modifiedBy":"ONEDATA","dateModified":"2009-12-15","deletedIndicator":"No"},{"value":"Moderate","valueDescription":"Moderate","ValueMeaning":{"publicId":"2955375","version":"1","preferredName":"Moderate","longName":"2955375","preferredDefinition":"Signs and symptoms of chronic GVHD interfere somewhat with function despite appropriate therapy or are progressive through first line systemic therapy (corticosteroids and/or cyclosporine or FK 506)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"767278B8-77C9-4D95-E040-BB89AD4364D6","latestVersionIndicator":"Yes","beginDate":"2009-10-21","endDate":null,"createdBy":"NYCHM","dateCreated":"2009-10-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7AC59585-5F76-0358-E040-BB89AD436BCF","beginDate":"2009-12-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-12-15","modifiedBy":"ONEDATA","dateModified":"2009-12-15","deletedIndicator":"No"},{"value":"Severe","valueDescription":"Severe","ValueMeaning":{"publicId":"2563416","version":"1","preferredName":"Severe","longName":"2563416","preferredDefinition":"Severe","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-C4C5-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-10-11","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-11","modifiedBy":"MMADDINENI","dateModified":"2023-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7AC59585-5F81-0358-E040-BB89AD436BCF","beginDate":"2009-12-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-12-15","modifiedBy":"ONEDATA","dateModified":"2009-12-15","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008547","version":"1","preferredName":"Specimen Characteristics","preferredDefinition":"attributes of a patient's laboratory sample, including the source, condition, and fixative.","longName":"SPEC_CHAR","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22908C4-638F-4A74-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2969450","version":"1","preferredName":"Cell Inflammatory Change Category","preferredDefinition":"The smallest units of living structure capable of independent existence, composed of a membrane-enclosed mass of protoplasm and containing a nucleus or nucleoid.:Inflammatory; relating to inflammation.:alteration or modification.:Category; used informally to mean a class of things.","longName":"C12508:C25535:C25446:C25372","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cell","conceptCode":"C12508","definition":"The smallest units of living structure capable of independent existence, composed of a membrane-enclosed mass of protoplasm and containing a nucleus or nucleoid.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Inflammatory","conceptCode":"C25535","definition":"Relating to inflammation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Change","conceptCode":"C25446","definition":"The act of alteration or modification; changed or altered in form or character.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Category","conceptCode":"C25372","definition":"A grouping of items based on some commonality or by user defined characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7AC59585-5F3D-0358-E040-BB89AD436BCF","latestVersionIndicator":"Yes","beginDate":"2009-12-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-12-15","modifiedBy":"ONEDATA","dateModified":"2009-12-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7AC59585-5F4E-0358-E040-BB89AD436BCF","latestVersionIndicator":"Yes","beginDate":"2009-12-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-12-15","modifiedBy":"ONEDATA","dateModified":"2009-12-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008601","version":"1","longName":"C3D Domain","context":"CCR","ClassificationSchemeItems":[{"publicId":"2812367","version":"1","longName":"caBIG","context":"CCR"}]},{"publicId":"2182125","version":"1","longName":"CCR Implementation","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811673","version":"1","longName":"C3D","context":"CCR"}]},{"publicId":"2931931","version":"1","longName":"Iloprost Trial","context":"SPOREs","ClassificationSchemeItems":[{"publicId":"2931952","version":"1","longName":"Iloprost 12079","context":"SPOREs"}]},{"publicId":"3896529","version":"1","longName":"Consortia 2012 Studies","context":"DCP","ClassificationSchemeItems":[{"publicId":"4528056","version":"1","longName":"NWU2013-02-01","context":"DCP"}]}],"AlternateNames":[{"name":"DCP","type":"USED_BY","context":"DCP"}],"ReferenceDocuments":[{"name":"Inflammatory Change","type":"Preferred Question Text","description":"Inflammatory Change","url":null,"context":"SPOREs"},{"name":"DCP Text 1","type":"Alternate Question Text","description":"Inflammation","url":null,"context":"DCP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7AC59585-5F8C-0358-E040-BB89AD436BCF","latestVersionIndicator":"Yes","beginDate":"2009-12-15","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-12-15","modifiedBy":"HARTLEYG","dateModified":"2015-01-06","changeDescription":"Curated to support Iloprost trial 12079 at U of Colorado.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}